Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tanespimycin and Gemcitabine in Metastatic Pancreatic Cancer
NCT00577889Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Mar 2008
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tanespimycin in pancreatic adenocarcinoma (PDAC), sponsored by National Cancer Institute. Started Mar 2008; status: completed.
02
Drugs
tanespimycin
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00577889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00577889.